A once-weekly dual-action protocol for members who want deeper appetite control and stronger metabolic results — paced by a clinician, not a calendar.
Tirzepatide is a single molecule engineered to act on two metabolic receptors at once: GLP-1 (the same lever semaglutide pulls) and GIP, a sister incretin that further modulates how your body handles food, fat storage, and insulin sensitivity. The dual mechanism is why members typically describe its effects as more pronounced — appetite signals quiet earlier in titration, and the metabolic response tends to be stronger.
A weekly subcutaneous injection delivers a steady level of activity for the full seven days. Your gut empties more slowly, satiety arrives sooner, and the brain's relationship with food often resets in ways that feel less like discipline and more like clarity.
Because the early effects can be more intense than with a single-receptor GLP-1, your clinician begins at a conservative dose and titrates upward over weeks rather than days. The first month is paced deliberately — fast enough to make a difference, slow enough to keep nausea and fatigue manageable.
Compounded tirzepatide is dispensed only by accredited 503A or 503B U.S. pharmacies under your clinician's order, with each batch tested for potency, sterility, pH, and endotoxins.
Every member's curve is a little different. The shape below is the typical clinician-guided arc.
You begin at a conservative dose to let your gut acclimate. Many members notice early fullness within days.
Your clinician reviews tolerance and steps the dose up if appropriate. Cravings typically quiet markedly.
First formal check-in: weight, side-effect profile, labs. Dose is held, advanced, or paused based on response.
Most members find a sustainable maintenance dose. Some taper. Either way, your clinician guides the off-ramp deliberately.
Tirzepatide isn't for everyone, and we don't pretend otherwise. Your clinician will confirm fit during your eligibility review.
More common in early titration than with single-receptor GLP-1s. Slower dose escalation, smaller meals, and an as-needed antiemetic typically resolve it.
Lower intake plus shifting metabolism can dent energy in weeks 1–4. Hydration, electrolytes, and protein targets usually restore it.
Slower gastric emptying changes transit time. Daily fiber, magnesium glycinate, and water targets are part of the protocol.
Mild redness or itch at the site is uncommon and self-resolving. Rotating sites and warming the dose to room temperature both help.
Billed monthly. Pause or cancel from your dashboard in one click. Final price is set after clinician review and may vary based on dose and protocol.
Take the twelve-minute eligibility review. A licensed clinician will read your intake, recommend a protocol — or tell you honestly that we're not the right fit. Either way, you'll know within a day.